{
  "ticker": "NBIX",
  "success": true,
  "price": {
    "current": 137.96,
    "currency": "USD",
    "day_high": 138.01,
    "day_low": 133.405,
    "52_week_high": 160.18,
    "52_week_low": 84.23
  },
  "market_cap": {
    "value": 13755398144.0,
    "currency": "USD"
  },
  "shares_outstanding": 99705698.0,
  "volume": {
    "last": 896795,
    "average_30d": 1104384
  },
  "valuation": {
    "pe_ratio": 32.926014,
    "forward_pe": 15.003496,
    "price_to_book": 4.5794334
  },
  "company_info": {
    "name": "Neurocrine Biosciences, Inc.",
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Specialty & Generic"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 4265700000.0,
    "total_liabilities": 1262100000.0,
    "stockholders_equity": 3003600000.0,
    "cash": 340200000.0,
    "marketable_securities": 774600000.0,
    "total_liquidity": 1114800000.0,
    "total_debt": 428400000.0,
    "long_term_debt": 428400000.0,
    "current_debt": null,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": 227500000.0,
    "free_cash_flow": 214300000.0,
    "investing_cash_flow": -196700000.0,
    "financing_cash_flow": 45600000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 541600000.0,
    "research_and_development": 250000000.0,
    "interest_expense": null,
    "net_income": 209500000.0,
    "revenue": 794900000.0,
    "gross_profit": 780900000.0,
    "ebitda": 247000000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:49:42.501811",
    "url": "https://finance.yahoo.com/quote/NBIX",
    "data_hash": "0eff978c627659de"
  }
}